Power Lung Versus Acapella After Coronary Artery Bypass Graft Surgery

Not Applicable

Active, not recruiting

• Conditions: Coronary Artery Bypass Graft Surgery
• Interventions: Device: Acapella device; Device: Power lung device; Other: routine Physical Therapy program

• Registration Number: NCT05260944
• Lead Sponsor: South Valley University

Brief Summary

The purpose of the study is to compare between the power lung versus acapella on airway clearance after coronary artery bypass graft surgery.

Detailed Description

In this part of the study the materials and methods will be presented under the following headings: subjects, equipments, procedures of the study and statistical procedures

1. Subjects. Ninty patients of both sexes will participate in this study with an age range of 40 to 50 years old. They will be chosen from outpatient clinic, Qena University Hospital.

Patients will be randomely assigned into three groups:

Group A: patients will receive a two supervised sessions using acapella device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration.

Group B: patients will receive a two supervised session using power lung device three sets for 10 repetitions two times daily from first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, Percussion and vibration).

Group C. Patients will receive only routine physical Therapy program.

2. Equipment:

1. For evaluation: Arterial blood gases including: - paO2, paCO2, PH and O2 saturation. Spirometry measurements: - as forced vital capacity (FVC) andbforced expiratory volume in the first second (FEV1).

The incidence of PPCs and the length of postoperative stay: - using the Melbourne Group Scale Dyspnea. According to the revised or modified Borg scale or rating of perceived exersion.

The Rand SF 36 health survey questionnaire. 2. For treatment The power lung device. Acapella device.

Study Timeline

• Study Start: 2021-08-05
• Study First Submitted: 2022-02-08
• Study First Submitted QC: 2022-02-19
• Study First Posted: 2022-03-02
• Status Verified: 2023-04
• Last Update Submitted: 2023-04-20
• Last Update Posted: 2023-04-21
• Primary Completion: 2023-07-05
• Study Completion: 2023-08-05

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• They will be from 40-50 years old.
• They will be patients undergo elective CABG surgery.
• Non productive cough postoperatively.
• Cough pain intensity > 5 as rated on a visual analogue scale (VAS) on postoperative day 1.

Exclusion Criteria

• Patients with chronic chest diseases.
• Patients with an intensive postoperative care (ICU) stay > 48 hrs.
• Uncooperative patients.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group A	Acapella device	Group A. Thirty patients will receive a two supervised session using Acapella three sets for 10 repetitions two times daily from first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, Percussion and vibration).
Group B	Power lung device	Thirty patients will receive a two supervised sessions using power lung device three sets for 10 repetitions from the first day postoperative until 7 days(André L.et al., 2016), in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration).
Group C	routine Physical Therapy program	Thirty patients will receive only routine physical Therapy program.

Primary Outcome Measures

Name	Time	Method
Arterial blood gases including:	One week	Partial pressure of oxygen (paO2), partial pressure of carbon dioxide (paCO2), power of hydrogen (PH)and O2 saturation.

Secondary Outcome Measures

Name	Time	Method
Spirometry	One week	As forced vital capacity (FVC), forced expiratory volume in the first second (FEV1) and the FEV1/FVC.

Trial Locations

Locations (1)

Shymaa yussuf abo zaid; 🇪🇬 Qinā, Egypt